Insulet Corporation Equity-NMS: PODD

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$272.63

Today's high :

$276.37

52W high :

$335.91

1Y :

29.35%

5Y :

195.7%

EPS(TTM): :

0.0086

Shares O/S :

69.7 M

Market cap :

19 B

What is the share price of Insulet Corporation today?

Insulet Corporation (PODD) share price as of May 30, 2023, is $272.58. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Insulet Corporation?

Yes, Indian Investors can invest in the Insulet Corporation (PODD) Share by opening an international trading account with Angel One.

How can I purchase Insulet Corporation shares in India?

Purchasing Insulet Corporation (PODD) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Insulet Corporation (PODD) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Insulet Corporation?

Yes, you can purchase fractional shares of Insulet Corporation (PODD) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Insulet Corporation?

The market capitalization of Insulet Corporation on May 30, 2023, is $19 B.

In which sector Insulet Corporation belongs?

Insulet Corporation operates in the Healthcare sector, specifically in the Medical Devices industry.

What documents are required to invest in Insulet Corporation stocks?

In order to invest in Insulet Corporation (PODD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Insulet Corporation is primarily engaged in the development, manufacture and sale of its Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Classic Omnipod), the Omnipod DASH Insulin Management System (Omnipod DASH), and the Omnipod 5 Automated Insulin Delivery System (Omnipod 5). The Omnipod System features a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body for up to three days at a time, which delivers personalized doses of insulin, and the Personal Diabetes Manager (PDM) or Controller, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and wirelessly monitors the Pod's operation. The Company sells Pods to Amgen Inc. (Amgen) for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta.